INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
SEC FORM 4/Open-market saleVerified dataRule 10b5-1 plan

Borgeson John A. sold KOD

Chief Financial Officer · Kodiak Sciences Inc. · Common Stock

Side
SELL
Value
$150K
Shares
1,677
Price
$89.2
Executed
Oct 21, 2026
Disclosed
Oct 23, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Oct 21 executedOct 23, 2026 disclosed

KOD · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
8/ 100 · ROUTINE
Methodology →
  • Transaction type+6 / 20

    Open-market sale

  • Relative size+4 / 25

    $150K reported value · 0.7% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • Pre-arranged plan-10

    Executed under a Rule 10b5-1 trading plan

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · KOD

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    YT
    Yang TaiyinDirector
    KODKodiak Sciences Inc.
    Option exercise
    		M$47K
    20.0K sh
    		Oct 23, 2026Oct 26, 2026
    traded Oct 23, 2026
    		+3dSEC FORM 4

    Evidence

    9
    YT
    Yang TaiyinDirector
    KODKodiak Sciences Inc.
    Option exercise
    		M—
    20.0K sh
    		Oct 23, 2026Oct 26, 2026
    traded Oct 23, 2026
    		+3dSEC FORM 4

    Evidence

    11
    BA
    Borgeson John A.Chief Financial Officer
    KODKodiak Sciences Inc.
    Open-market sale · 10b5-1 plan
    		SELL$746K
    8,514 sh
    		Oct 21, 2026Oct 23, 2026
    traded Oct 21, 2026
    		+2dSEC FORM 4

    Evidence

    11
    BA
    Borgeson John A.Chief Financial Officer
    KODKodiak Sciences Inc.
    Open-market sale · 10b5-1 plan
    		SELL$684K
    7,623 sh
    		Oct 21, 2026Oct 23, 2026
    traded Oct 21, 2026
    		+2dSEC FORM 4

    Evidence

    11
    BA
    Borgeson John A.Chief Financial Officer
    KODKodiak Sciences Inc.
    Open-market sale · 10b5-1 plan
    		SELL$464K
    5,101 sh
    		Oct 21, 2026Oct 23, 2026
    traded Oct 21, 2026
    		+2dSEC FORM 4

    Evidence

    11
    BA
    Borgeson John A.Chief Financial Officer
    KODKodiak Sciences Inc.
    Open-market sale · 10b5-1 plan
    		SELL$274K
    2,985 sh
    		Oct 21, 2026Oct 23, 2026
    traded Oct 21, 2026
    		+2dSEC FORM 4

    Evidence

    8
    BA
    Borgeson John A.Chief Financial Officer
    KODKodiak Sciences Inc.
    Open-market sale · 10b5-1 plan
    		SELL$185K
    2,000 sh
    		Oct 21, 2026Oct 23, 2026
    traded Oct 21, 2026
    		+2dSEC FORM 4

    Evidence

    8
    BA
    Borgeson John A.Chief Financial Officer
    KODKodiak Sciences Inc.
    Open-market sale · 10b5-1 plan
    		SELL$187K
    2,000 sh
    		Oct 21, 2026Oct 23, 2026
    traded Oct 21, 2026
    		+2dSEC FORM 4

    Evidence

    3
    BA
    Borgeson John A.Chief Financial Officer
    KODKodiak Sciences Inc.
    Option exercise · 10b5-1 plan
    		M—
    30.0K sh
    		Oct 21, 2026Oct 23, 2026
    traded Oct 21, 2026
    		+2dSEC FORM 4

    Evidence

    5
    BA
    Borgeson John A.Chief Financial Officer
    KODKodiak Sciences Inc.
    Open-market sale · 10b5-1 plan
    		SELL$9,491
    100 sh
    		Oct 21, 2026Oct 23, 2026
    traded Oct 21, 2026
    		+2dSEC FORM 4

    Evidence

    6
    BA
    Borgeson John A.Chief Financial Officer
    KODKodiak Sciences Inc.
    Option exercise · 10b5-1 plan
    		M$75K
    30.0K sh
    		Oct 21, 2026Oct 23, 2026
    traded Oct 21, 2026
    		+2dSEC FORM 4

    Evidence

    9
    PV
    Perlroth VictorDirector, Chairman and CEO, 10% Owner
    KODKodiak Sciences Inc.
    Option exercise
    		M—
    314.7K sh
    		Sep 25, 2026Sep 29, 2026
    traded Sep 25, 2026
    		+4dSEC FORM 4

    Evidence

    26
    PV
    Perlroth VictorDirector, Chairman and CEO, 10% Owner
    KODKodiak Sciences Inc.
    Option exercise
    		M$3.23M
    600.0K sh
    		Sep 25, 2026Sep 29, 2026
    traded Sep 25, 2026
    		+4dSEC FORM 4

    Evidence

    19
    PV
    Perlroth VictorDirector, Chairman and CEO, 10% Owner
    KODKodiak Sciences Inc.
    Option exercise
    		M$911K
    365.8K sh
    		Sep 25, 2026Sep 29, 2026
    traded Sep 25, 2026
    		+4dSEC FORM 4

    Evidence

    22
    PV
    Perlroth VictorDirector, Chairman and CEO, 10% Owner
    KODKodiak Sciences Inc.
    Option exercise
    		M$1.24M
    314.7K sh
    		Sep 25, 2026Sep 29, 2026
    traded Sep 25, 2026
    		+4dSEC FORM 4

    Evidence

    9
    PV
    Perlroth VictorDirector, Chairman and CEO, 10% Owner
    KODKodiak Sciences Inc.
    Option exercise
    		M—
    600.0K sh
    		Sep 25, 2026Sep 29, 2026
    traded Sep 25, 2026
    		+4dSEC FORM 4

    Evidence

    9
    PV
    Perlroth VictorDirector, Chairman and CEO, 10% Owner
    KODKodiak Sciences Inc.
    Option exercise
    		M—
    365.8K sh
    		Sep 25, 2026Sep 29, 2026
    traded Sep 25, 2026
    		+4dSEC FORM 4

    Evidence

    13
    BA
    Borgeson John A.Chief Financial Officer
    KODKodiak Sciences Inc.
    Option exercise
    		M$30K
    28.6K sh
    		Apr 15, 2026Apr 16, 2026
    traded Apr 15, 2026
    		+1dSEC FORM 4

    Evidence

    21
    BA
    Borgeson John A.Chief Financial Officer
    KODKodiak Sciences Inc.
    Option exercise
    		M—
    28.6K sh
    		Apr 15, 2026Apr 16, 2026
    traded Apr 15, 2026
    		+1dSEC FORM 4

    Evidence

    19
    PV
    Perlroth VictorDirector, Chairman and CEO
    KODKodiak Sciences Inc.
    Option exercise
    		M$312K
    300.0K sh
    		Mar 25, 2026Mar 27, 2026
    traded Mar 25, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001754045-26-000010
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Oct 21, 2026
    Published
    Oct 23, 2026
    Ingested by INSIDER
    Nov 5, 02:09 UTC
    Last re-read
    Nov 5, 02:09 UTC

    Extracted facts

    Filer
    Borgeson John A.
    Role
    Chief Financial Officer
    Transaction
    Open-market saleAs filed: “S”
    Asset
    Kodiak Sciences Inc.
    Ticker
    KOD
    Shares
    1,677
    Price per share
    $89.2
    Value
    $149,588
    Execution date (reported)
    Oct 21, 2026
    Owned after transaction
    231.7K shares
    Rule 10b5-1 plan
    Yes, as checked by the filer
    Days from execution to publication
    2

    Calculation

    Value = shares × reported price per share

    • Shares: 1,677
    • Price: $89.2

    = $149,588

    What this establishes

    Borgeson John A. filed this Form 4 reporting a open-market sale of KOD on Oct 21, 2026. It became public on Oct 23, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Financial Officer
    Borgeson John A.cik:0001754045
    Issuer
    Kodiak Sciences Inc.cik:0001468748

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.